Form 4: Champions Oncology Director Philip P. Breitfeld Reports Share Disposal

Director Philip P. Breitfeld reported the disposal of 4,150 shares of Champions Oncology, Inc. common stock via a transfer to a donor-advised charitable trust fund.

Summary

• On March 25, 2025, Philip P. Breitfeld, a director of Champions Oncology, Inc., reported a transaction involving the company's common stock.
• Breitfeld disposed of 4,150 shares, transferring them to a donor-advised charitable trust fund.
• The trust fund subsequently sold the shares.
• Following the transaction, Breitfeld directly owns 5,717 shares of Champions Oncology, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction. The disposal of shares by a director could be seen as slightly negative, but the context of a charitable donation mitigates this.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This transaction is a relatively small disposal of shares by a director.

Stakeholder Impact

• The disposal of shares could have a minor impact on shareholders if it signals a lack of confidence by the director, although the charitable donation context lessens this concern.

Key Dates

Keywords

Champions Oncology, CSBR, Form 4, Beneficial Ownership, Director, Philip P. Breitfeld, Share Disposal, Charitable Trust